Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate, 95.0%, 5g

6-Bromo-2-methylimidazo[1,2-b]pyridazine, 97%, 250mg

1-(3-Methoxypropyl)piperidin-4-amine, 95.0%, 1g

Cyclopropylisocyanide, 96.0%, 5g

N'-Hydroxyoxane-4-carboximidamide, 1g

5-Methylpiperidin-2-one, 95.0%, 1g

(R)-2-Phenyl-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetonitrile, 95%, 1g

Ethyl 5-oxopyrrolidine-3-carboxylate, 95.0%, 5g

N-Methyl-1-(4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)methanamine hydrochloride, 100mg

2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid, 95.0%, 1g

2-(Trifluoromethyl)pyrimidine-4-carboxylic acid, 95.0%, 100mg

Octyldimethylammoniopropanesulfonate, min. 98% for biochemistry, 5 g, glass packaging

2-Hydroxy-2-(4-hydroxyphenyl)acetonitrile, 98%, 250mg